Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 18, 2026 1 hour, 59 minutes ago
Medical News: Growing Concerns Over a Common Diabetes Drug
Metformin has long been considered a cornerstone treatment for type 2 diabetes, widely prescribed across the world due to its effectiveness and affordability. However, new research is raising serious concerns about its safety in a very specific and vulnerable group: elderly patients with chronic kidney disease. As populations continue to age, understanding how commonly used drugs behave in older bodies has become more important than ever.
Common diabetes drug may pose serious risks for elderly patients with kidney disease, new study warns
A recent study conducted by researchers from Azienda Sociosanitaria Ligure 5 in La Spezia, Italy, sheds new light on this issue. The research focused on patients aged over 78 who were living with both type 2 diabetes and chronic kidney disease, a combination that already places them at higher health risk.
Study Design and Patient Profile
The study followed 624 elderly patients over a median period of nearly three years. Among them, 309 patients were treated with metformin, while 315 were not. All participants had moderate kidney impairment but still maintained kidney function above the threshold typically considered safe for metformin use.
Researchers tracked several serious outcomes, including admission to intensive care units, the need for dialysis, development of lactic acidosis, and death from any cause. These outcomes were combined into what scientists call a “composite endpoint,” allowing them to assess overall risk in a meaningful way.
Key Findings Reveal Higher Risks
The results were striking. Patients taking metformin experienced significantly more adverse events compared to those who were not on the drug. Specifically, 18.7 percent of metformin users encountered serious complications versus just 9.5 percent in the control group.
One of the most concerning findings was the increased risk of lactic acidosis, a rare but potentially life-threatening condition where lactic acid builds up in the bloodstream. The study found that metformin users were more than three times as likely to develop this condition. Additionally, these patients were more than twice as likely to require intensive care and nearly twice as likely to need kidney replacement therapy such as dialysis.
Interestingly, while death rates were higher among metformin users, the difference was not statistically strong enough to confirm a direct link. Still, the trend added to the growing concern about the drug’s safety in this population.
Why Older Patients Face Greater Danger
This
Medical News report highlights that aging bodies process medications differently. As kidney function naturally declines with age, drugs like metformin, which are primarily cleared through the kidneys, can accumulate in the body. This buildup increases the risk of toxic side effects.
Older adults are also more likely to experience sudden health chan
ges such as dehydration or infections, which can further strain the kidneys. Many are also taking multiple medications, increasing the chances of drug interactions that can worsen kidney function.
The study suggests that these combined factors may explain why metformin, generally considered safe in younger populations, behaves differently in very elderly patients.
Consistent Findings Strengthen the Evidence
To ensure the results were reliable, researchers used advanced statistical techniques to match patients with similar health profiles. Even after adjusting for differences such as age, heart disease, and cancer history, the increased risks associated with metformin remained consistent.
Additional analysis showed that when outcomes were ranked by severity, patients not taking metformin had better overall results. This reinforces the concern that the drug may pose hidden dangers in this fragile group.
What This Means for Patients and Doctors
The findings do not suggest that metformin should be abandoned altogether. Instead, they point to the need for a more cautious and personalized approach. Doctors may need to monitor kidney function more closely in elderly patients and consider stopping the drug during periods of illness or dehydration.
Conclusion
The study provides important insights into how a widely trusted medication may carry unexpected risks in very elderly individuals with kidney disease. While metformin remains beneficial for many people, its use in older patients should no longer be seen as routine. Careful evaluation of each patient’s condition, closer monitoring, and timely adjustments in treatment could help reduce the risk of serious complications. As the global population continues to age, such findings underscore the importance of tailoring medical care to the unique needs of older adults rather than relying solely on data derived from younger populations.
The study findings were published in the peer reviewed journal: Medicina.
https://www.mdpi.com/1648-9144/62/4/776
For the latest on dangers of metformin for the elderly, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/nephrology-(kidneys)
https://www.thailandmedical.news/articles/diabetes
https://www.thailandmedical.news/articles/med-news
Share
Tweet
Share
